APA (7th ed.) Citation

SA, H., & BA, S. (2023). The argument against the use of dupilumab in patients with limited polyp burden in chronic rhinosinusitis with nasal polyposis (CRSwNP). Journal of otolaryngology - head & neck surgery = Le Journal d'oto-rhino-laryngologie et de chirurgie cervico-faciale, 52(1), 64. https://doi.org/10.1186/s40463-023-00668-z

Chicago Style (17th ed.) Citation

SA, Hardison, and Senior BA. "The Argument Against the Use of Dupilumab in Patients with Limited Polyp Burden in Chronic Rhinosinusitis with Nasal Polyposis (CRSwNP)." Journal of Otolaryngology - Head & Neck Surgery = Le Journal D'oto-rhino-laryngologie Et De Chirurgie Cervico-faciale 52, no. 1 (2023): 64. https://doi.org/10.1186/s40463-023-00668-z.

MLA (9th ed.) Citation

SA, Hardison, and Senior BA. "The Argument Against the Use of Dupilumab in Patients with Limited Polyp Burden in Chronic Rhinosinusitis with Nasal Polyposis (CRSwNP)." Journal of Otolaryngology - Head & Neck Surgery = Le Journal D'oto-rhino-laryngologie Et De Chirurgie Cervico-faciale, vol. 52, no. 1, 2023, p. 64, https://doi.org/10.1186/s40463-023-00668-z.